These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30599218)

  • 41. Relative contribution of peripheral versus central opioid receptors to antinociception.
    Labuz D; Mousa SA; Schäfer M; Stein C; Machelska H
    Brain Res; 2007 Jul; 1160():30-8. PubMed ID: 17599812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors.
    Kamei J; Saitoh A; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Life Sci; 1995 Mar; 56(15):PL285-90. PubMed ID: 8614238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L; Noviello L; Noviello V
    Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone.
    Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Sato T; Zadina JE; Kastin AJ; Sakurada T
    Peptides; 2002 May; 23(5):895-901. PubMed ID: 12084520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
    J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide S produces antinociceptive effects at the supraspinal level in mice.
    Li W; Chang M; Peng YL; Gao YH; Zhang JN; Han RW; Wang R
    Regul Pept; 2009 Aug; 156(1-3):90-5. PubMed ID: 19345242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.
    Ochi T; Fujii T; Motoyama Y; Goto T
    Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
    Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
    Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
    Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
    Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
    Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors.
    Matsumoto K; Mizowaki M; Suchitra T; Takayama H; Sakai S; Aimi N; Watanabe H
    Life Sci; 1996; 59(14):1149-55. PubMed ID: 8831802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
    Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level.
    Fu CY; Yang Q; Wang KR; Kong ZQ; Chen Q; Wang R
    Behav Brain Res; 2006 Jun; 170(2):293-301. PubMed ID: 16621052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.